DecisionView develops innovative software solutions that optimize the clinical performance of life sciences organizations around the world. By uniquely converging predictive analytics, simulation, visualization and data aggregation capabilities into functionally rich and easy to use applications, the company's solutions deliver proven business value in faster cycle times, reducing clinical costs and improving clinical productivity. Granite Ventures and Aeris Capital are primary investors in the company.
